+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Evaluation of sigma (σ) receptors in the antidepressant-like effects of ketamine in vitro and in vivo



Evaluation of sigma (σ) receptors in the antidepressant-like effects of ketamine in vitro and in vivo



European Neuropsychopharmacology 22(4): 308-317



Ketamine is an NMDA antagonist and dissociative anesthetic that has been shown to display rapid acting and prolonged antidepressant activity in small-scale human clinical trials. Ketamine also binds to σ receptors, which are believed to be protein targets for a potential new class of antidepressant medications. The purpose of this study was to determine the involvement of σ receptors in the antidepressant-like actions of ketamine. Competition binding assays were performed to assess the affinity of ketamine for σ(1) and σ(2) receptors. The antidepressant-like effects of ketamine were assessed in vitro using a neurite outgrowth model and PC12 cells, and in vivo using the forced swim test. The σ receptor antagonists, NE-100 and BD1047, were evaluated in conjunction with ketamine in these assays to determine the involvement of σ receptors in the antidepressant-like effects of ketamine. Ketamine bound to both σ(1) and σ(2) receptors with μM affinities. Additionally, ketamine potentiated NGF-induced neurite outgrowth in PC12 cells and this effect was attenuated in the presence of NE-100. Ketamine also displayed antidepressant-like effects in the forced swim test; however, these effects were not attenuated by pretreatment with NE-100 or BD1047. Taken together, these data suggest that σ receptor-mediated neuronal remodeling may contribute to the antidepressant effects of ketamine.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 036203170

Download citation: RISBibTeXText

PMID: 21911285

DOI: 10.1016/j.euroneuro.2011.08.002


Related references

Attenuation of methamphetamine-induced effects through the antagonism of sigma (sigma) receptors: Evidence from in vivo and in vitro studies. European Neuropsychopharmacology 18(12): 871-881, 2008

In vitro and ex vivo characterization of sigma-1 and sigma-2 receptors: agonists and antagonists in biological assays. Central Nervous System Agents in Medicinal Chemistry 9(3): 161-171, 2009

Synthesis of 99mTc-nitrido heterocomplex of piperidine and in vitro and in vivo evaluation of its affinity for sigma receptors. Cancer BioTherapy and Radiopharmaceuticals 23(1): 34-42, 2008

In vitro modulation of sigma-1 receptors in mouse forebrain by antidepressant drugs. Journal of Psychopharmacology (ABSTR BOOK): A2, 1993

Involvement of sigma-1 receptors in the antidepressant-like effects of dextromethorphan. Plos one 9(2): E89985, 2014

Significance of sigma opioid receptors for the cardiovascular effects of intrathecal ketamine in cats. Asia Pacific Journal of Pharmacology 5(1): 47-50, 1990

(+) 3-[3-hydroxyphenyl-N-(1-propyl) piperidine] selectively differentiates effects of sigma ligands on neurochemical pathways modulated by sigma receptors: evidence for subtypes, in vivo. Neuropharmacology 30(8): 915-922, 1991

Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine. Pharmacology Biochemistry and Behavior 181: 53-59, 2019

Comparative in vivo and in vitro autoradiography of sigma receptors in the mouse brain Evidence for in vivo interactions with NPY- and CGRP-related peptides. Society for Neuroscience Abstracts 20(1-2): 747, 1994

Antidepressant-like effects of ascorbic acid and ketamine involve modulation of GABAA and GABAB receptors. Pharmacological Reports 68(5): 996, 2016

Ketamine may exert antidepressant effects via suppressing NLRP3 inflammasome to upregulate AMPA receptors. Neuropharmacology 146: 149-153, 2019

Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism. Journal of Psychiatry and Neuroscience 42(4): 222-229, 2017

Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex. European Psychiatry 29(7): 419-423, 2014

Development of molecular probes for imaging sigma-2 receptors in vitro and in vivo. Central Nervous System Agents in Medicinal Chemistry 9(3): 230-245, 2009

Novel sigma (sigma) receptor agonists produce antidepressant-like effects in mice. European Neuropsychopharmacology 17(11): 708-716, 2007